Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer for which there is no effective treatment. Previously, we and others demonstrated that CXCR4 surface expression is an independent prognostic factor for disease relapse and survival in breast cancer. In this study, we investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Sixian, Peng, Xun, Li, Xiaoli, Yang, Ping, Xie, Linhao, Li, Yaochen, Du, Caiwen, Zhang, Guojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359214/
https://www.ncbi.nlm.nih.gov/pubmed/25544759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359214/
https://www.ncbi.nlm.nih.gov/pubmed/25544759

Ejemplares similares